The Japan Diabetes Society

JapaneseEnglish

Vol.14 - No.4 (October 2023)

Vol.14 - No.4 (October 2023)

Review Article

Review Article

Association between dietary carbohydrate intake and risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies
Akinori Yaegashi, Satoshi Sunohara, Takashi Kimura, Wen Hao, Takato Moriguchi & Akiko Tamakoshi 327–338

Original Article

Determinants of phase angle in Japanese patients with diabetes
Naokazu Muramae, Tomokazu Matsuda, Satoshi Inagaki, Hiroaki Takahashi, Kozue Abe, Saki Nakatani, Michiko Takahashi, Kenji Kato, Kazuhiko Sakaguchi & Wataru Ogawa 339–343

Original Article

Anemia combined with albuminuria increases the risk of cardiovascular and renal events, regardless of a reduced glomerular filtration rate, in patients with type 2 diabetes: a prospective observational study
Hiroyuki Ito, Suzuko Matsumoto, Hideyuki Inoue, Takuma Izutsu, Eiji Kusano, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori & Michiko Togane 344–355

Original Article

Original Article

Use of diabetes medications in adults with T2D and CVD in Japan: secondary analysis of the CAPTURE study
Yukiko Onishi, Shinichiro Shirabe, Kosei Eguchi, Keiji Nishijima, Toshihiro Sato & Hiroaki Seino 363–371

Original Article

Original Article

Patients with gestational diabetes mellitus may be treated in both early and late pregnancy, especially in patients with pre-pregnancy overweight: A cross-sectional study in Japan
Ayaka Takemoto, Yoshio Nagai, Shin Kawanabe, Tomoko Nakagawa, Kaho Matsumoto, Jyunichi Hasegawa, Nao Suzuki, Yasushi Tanaka & Masakatsu Sone 381–389

Original Article

Effect of joint limitation and balance control on gait changes in diabetic peripheral neuropathy
Hiroyuki Yamasaki, Yoshiro Abe, Shunsuke Mima, Mayu Bando, Shinji Nagasaka, Yutaro Yamashita, Kazuhide Mineda, Akio Kuroda, Munehide Matsuhisa, Masahiro Takaiwa & Ichiro Hashimoto 390–396

Original Article

Original Article

Glucose control in the early phase of hospitalization is associated with severe prognosis in coronavirus disease 2019 (COVID-19) patients with diabetes in Japan
Yukiyoshi Okauchi, Ryuki Sakamoto, Tomoko Kaketaka, Eri Yamabayashi, Motohiro Kubori, Shinya Inada, Osamu Morimura, Yasushi Otani, Kinya Abe, Tsutomu Nishida & Hiromi Iwahashi 406–412

Original Article

Case Report

Anti-GAD antibody-positive fulminant type 1 diabetes developed following SARS-CoV-2 vaccination
Tomohito Izumi, Hironobu Takahashi & Hironori Takahashi 422–426

Short Communication

In vivo relationship between bound and free insulin in patients with diabetes having anti-insulin antibodies
Hiroyuki Asaka, Shigehiro Karashima, Daisuke Chujo, Mitsuhiro Kometani, Mikiya Usukura, Kunimasa Yagi, Ko Aiga & Takashi Yoneda 427–433

Short Communication

Effects of pemafibrate on left ventricular diastolic function in patients with type 2 diabetes mellitus: a pilot study
Kaoru Yamamoto, Yasuharu Ohta, Akihiko Taguchi, Masaru Akiyama, Hiroko Nakabayashi, Yuko Nagao, Hatanaka Ryoko, Yasuaki Wada, Takeshi Yamamoto, Masafumi Yano & Yukio Tanizawa 434–439

Short Communication

Correction

Correction

Correction: A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes
Ryotaro Bouchi, Tatsuya Kondo, Yasuharu Ohta, Atsushi Goto, Daisuke Tanaka, Hiroaki Satoh, Daisuke Yabe, Rimei Nishimura, Norio Harada, Hideki Kamiya, Ryo Suzuki & Toshimasa Yamauchi 446

Update: October 16, 2023

SUB MENU